Neurology Today in 5

By American Academy of Neurology

Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.


Category: Medicine

Open in Apple Podcasts


Open RSS feed


Open Website


Rate for this podcast

Subscribers: 52
Reviews: 0
Episodes: 100

Description

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

Episode Date
Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s
Nov 21, 2024
Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression
Nov 07, 2024
Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder
Oct 17, 2024
Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke
Oct 03, 2024
Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s
Sep 19, 2024
Alzheimer’s diagnosis criteria, AI and Parkinson’s severity, neurotoxicity of racism
Sep 05, 2024
Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice
Aug 15, 2024
Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer
Jul 31, 2024
Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab
Jul 18, 2024
Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology
Jul 04, 2024
When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.
Jun 20, 2024
Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics
Jun 06, 2024
Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers
May 16, 2024
Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies
May 02, 2024
ME/CFS and long COVID; negative outcomes for ALS drug; donanemab
Apr 18, 2024
BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine
Apr 04, 2024
SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens
Mar 21, 2024
AI and 911 stroke detection, iatrogenic Alzheimer’s and human growth hormone, seizure dogs and refractory epilepsy
Mar 07, 2024
Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders
Feb 12, 2024
Cerebral amyloid angiopathy and nontraumatic subdural hemorrhage, AI for neurology boards, weight loss drugs and neurologic conditions
Jan 25, 2024
Rising incidence of Creutzfeldt-Jakob disease, therapy for prodromal migraine, neurotrauma of blast injury
Jan 16, 2024
DBS and cognition in severe TBI, in utero exposure to antiseizure drugs, best advances of 2023
Jan 02, 2024
Parkinson’s and suicide risk; biomarkers and underrepresentation in Alzheimer’s trials, immune system changes in ALS and Parkinson’s.
Dec 21, 2023
Serotonin and long COVID, Afib detected 3 years after stroke, Medicare on PET amyloid scans
Dec 07, 2023
A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia.
Nov 16, 2023
Blood transfusions and spontaneous intracerebral hemorrhages, long distance travel to neurologists, biomarkers for Parkinson’s disease
Nov 02, 2023
Blood pressure and endovascular therapy, cutbacks in neurology CME, blood test for Alzheimer’s
Oct 19, 2023
Football and Parkinson’s, deep brain stimulation for stroke recovery, neuroprostheses for anarthric patients
Oct 05, 2023
Medicare coverage of carotid stenting, disparities in vulnerable neuro-oncology patients, optical EMG for neuromuscular disorders.
Sep 21, 2023
Endovascular treatment and intracranial tumors; guideline on IVIG use for neuromuscular disorders, pros and cons of donanemab.
Sep 07, 2023
Oral health and cognitive decline; managing first-ever sleep seizures; growth of concierge neurology.
Aug 17, 2023
Gene variants and MS severity, AI and EEG reads, neuroprotective agent for ischemic stroke
Aug 03, 2023
Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas.
Jul 20, 2023
Gout and risk of neurodegenereative diseases, Tenecteplase compared with warfarin, cognitive decline after heart attack
Jul 06, 2023
Antipsychotic for dementia-related agitation, contaminated water at Camp Lejeune associated with elevated risk for Parkinson’s, gene variant confers resilience against autosomal dominant Alzheimer’s.
Jun 15, 2023
OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy
Jun 01, 2023
Assay detects Parkinson’s before symptom onset; life stressors in pregnant women with epilepsy; role of inflammation in NORSE
May 18, 2023
Anticoagulants for patients with dementia and Afib, tau levels in women taking hormone replace therapy, neurohumanities programs for neurology residents.
May 04, 2023
Fertility treatments for women with MS, stroke systems of care, ravalizumab for NMOSD
Apr 20, 2023
Intranasal CGRP for migraine, ultrasound ablation for Parkinson’s disease, novel therapeutic pathway for Duchenne muscular atrophy.
Apr 06, 2023
Antipsychotics and dementia risk; biomarkers for lecanemab eligibility; trial of difelikefalin for neurogenic itch in notaliga paresthetica.
Mar 16, 2023
Pregnancy-associated stroke outcomes; a robotic device for shoulder movement in ALS; non-invasive neurostimulation for refractory seizures.
Mar 02, 2023
Acute infections and increased risk for dementia, alternatives to CPAP for sleep apnea; the legacy of Dr. Ralph Sacco.
Feb 16, 2023
IV thrombolysis for large vessel occlusion; impact of mindfulness, exercise on cognition;new brain layer in subarachnoid space.
Feb 02, 2023
Best advances of 2022, misdiagnosed autoimmune encephalitis, inflation his neurology private practice
Jan 19, 2023
Spinal cord stimulation for chronic pain, disparities in brain age by race/ethnicity, careers in teleneurology
Jan 04, 2023
Rituximab for MS, food security and cognition, in utero treatment for Pompe disease
Dec 15, 2022
Modifiable risk factors for monogenic stroke, health care systems prepare for wave of new Alzheimer’s therapies, criteria for selecting neurology residents
Dec 01, 2022
Revascular therapies for stroke patients with COVID, dementia and suicide risk, hyperbaric oxygen therapy for concussion in children.
Nov 17, 2022
Allergies and dementia risk, folic acid and risk of cancer in children of women with epilepsy, climate change and neurologic disorders.
Nov 03, 2022
Vamorolone for DMD, aquaporin protein and amyloid clearance, monkey pox-associated neurologic events.
Oct 20, 2022
Chronic kidney disease and risk for intracerebral hemorrhage, gonadotropic replacement and cogntion in Down syndrome, how to distinguish polio from other viruses
Oct 06, 2022
Decompression and Chiari malformation, atrial cardiopathy and dementia risk, 3D printing the brain.
Sep 15, 2022
Processed foods and dementia risk, therapies for vertigo, impostor syndrome
Sep 01, 2022
Spinal cord stimulation for diabetic neuropathy, Roe v. Wade reversal, diversifying the neurology pipeline.
Aug 18, 2022
Functional neurologic disorder, newborn screening for SMA, when to leave job
Aug 04, 2022
Functional neurologic disorder, newborn screening for SMA, when to leave job
Aug 04, 2022
Brain aneurysm rupture, COVID-19 exposure in utero, socioeconomics and brain development.
Jul 21, 2022
Monkeypox, soticelstat for epilepsy, gabapentin for stroke recovery.
Jul 07, 2022
Fenfluramine for LGS, social isolation and dementia risk, neurology’s status in NRMP match.
Jun 16, 2022
Teleneurology in rural America, trauma-informed neurology,advances in neurogenetics
Jun 02, 2022
Portable MRI for stroke, SSRIs and seizure risk in neonates, neurology training in Ukraine.
May 19, 2022
Blood pressure trajectories, Parkinson’s risk factors, neurology residents, Potamkin Award
May 05, 2022
Gabapentin as a controlled substance embolic stroke of undetermined source, how to become a clinician educator
Apr 21, 2022
Neurologists in Ukraine, neurology costs discussions, statins and parkinsonism
Apr 07, 2022
New Parkinson’s therapies, antiseizure drugs in pregnancy, endovascular therapy for large core stroke
Mar 17, 2022
Parkinson’s in women, gene therapy for LGMD, advance for severe SCI
Mar 03, 2022
Gender Bias in Medicare Criteria for Sleep Apnea and More
Feb 17, 2022
February 3-Issue Introduction
Feb 03, 2022
January 20- Issue Introduction
Jan 21, 2022
January 6- Issue Introduction
Jan 06, 2022
December 16- Issue Introduction
Dec 17, 2021
December 2- Issue Introduction
Dec 03, 2021
November 18 - Issue Introduction
Nov 19, 2021
November 4- Issue Introduction
Nov 08, 2021
October 21- Issue Introduction
Oct 21, 2021
October 7- Issue Introduction
Oct 07, 2021
September 16- Issue Introduction
Sep 16, 2021
September 2- Issue Introduction
Sep 04, 2021
August 19- Issue Introduction
Aug 24, 2021
August 5- Issue Introduction
Aug 05, 2021
July 22- Issue Introduction
Jul 22, 2021
July 8- Issue Introduction
Jul 09, 2021
June 17- Issue Introduction
Jun 17, 2021
June 3- Issue Introduction
Jun 03, 2021
May 20- Issue Introduction
May 19, 2021
May 6- Issue Introduction
May 06, 2021
April 15- Issue Introduction
Apr 15, 2021
April 1- Issue Introduction
Mar 31, 2021
March 4- Issue Introduction
Mar 04, 2021
February 18- Issue Introduction
Feb 17, 2021
February 21- Issue Introduction
Feb 03, 2021
January 21- Issue Introduction
Jan 21, 2021
January 7- Issue Introduction
Jan 05, 2021
December 17 - Issue Introduction
Dec 15, 2020
December 3- Issue Introduction
Dec 02, 2020
November 19- Issue Introduction
Nov 18, 2020
November 5- Issue Introduction
Nov 04, 2020
October 22- Issue Introduction
Oct 20, 2020
October 8- Issue Introduction
Oct 08, 2020